ArticleScientific reports2026
UCA1 copy number gain in serum cfDNA predicts next-generation antiandrogen resistance in metastatic castration-resistant prostate cancer.
Anita Csizmarik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.